Pain relief tablet Saridon exempted from list of banned FDCs by Supreme Court: Piramal Enterprises

In a regulatory filing, the company said the apex court has ruled in favour of Saridon, which is a heritage brand from its healthcare product portfolio.

Press Trust of India February 21, 2019 15:14:22 IST
Pain relief tablet Saridon exempted from list of banned FDCs by Supreme Court: Piramal Enterprises
  • In September 2018, PEL had been awarded a stay order from the Supreme Court on the ban

  • Last year in September, the government had banned 328 FDCs

  • The popularity of the brand is widespread with 31 tablets being sold every second

New Delhi: Piramal Enterprises Ltd (PEL) on Thursday said its pain relief tablet brand Saridon has been exempted from the list of banned fixed dose combinations (FDCs) by the Supreme Court.

In a regulatory filing, the company said the apex court has ruled in favour of Saridon, which is a heritage brand from its healthcare product portfolio.

"In September 2018, PEL had been awarded a stay order from the Supreme Court on the ban, which allowed it to continue manufacturing, distribution and sale of the FDC," it said.

Pain relief tablet Saridon exempted from list of banned FDCs by Supreme Court Piramal Enterprises

Ajay Piramal, chairman of Piramal group. Reuters

Commenting on the court order, PEL executive director Nandini Piramal said, "We are pleased with the Supreme Court ruling, as it is an affirmation to our commitment to provide effective and safe healthcare solutions that address unique needs of Indian consumers. We were confident that the law would prevail in our favour."

Last year in September, the government had banned 328 FDCs, which were termed 'irrational' on the basis of safety issues and lack of therapeutic justification.

Stating that Saridon is a "heritage brand trusted by customers for the last 50 years in India", Piramal said, "This exemption from the banned list of FDCs validates our intent to serve our customers with the highest levels of integrity."

Piramal further said, "We continue to expand our healthcare product portfolio with an aim to be amongst the top three over the-counter (OTC) product companies in India by 2020".

Citing a study by AC Neilson, PEL said the addressable analgesic market is Rs 6,450 crore, of which analgesic tablet market is Rs 2,050 crore as of December, 2018. The popularity of the brand is widespread with 31 tablets being sold every second.

PEL said Saridon is available across a distribution network of 9 lakh outlets in India.

Updated Date:

also read

SC questions appointment process of EC Arun Goel, AG for Centre asks court to hold its mouth
India

SC questions appointment process of EC Arun Goel, AG for Centre asks court to hold its mouth

The bench said 1985-batch IAS officer Goel got voluntary retirement from service in a single day, his file was cleared by the Law Ministry in a single day

Supreme Court directs Centre to produce file related to appointment of Election Commissioner Arun Goel
India

Supreme Court directs Centre to produce file related to appointment of Election Commissioner Arun Goel

A five-judge Constitution bench headed by Justice K M Joseph said it wants to know whether there was any “hanky panky” in Goel's appointment as election commissioner as he was only recently given voluntary retirement from service

Why Madhya Pradesh is moving SC over the law that wants to make conversion illegal
Explainers

Why Madhya Pradesh is moving SC over the law that wants to make conversion illegal

The move comes after Madhya Pradesh High Court passed an interim order stopping the government from prosecuting interfaith couples who marry without giving the district magistrate a 60-day notice — mandated under Section 10 of the MP Freedom of Religion Act (MPFRA) 2021